
A2A
A2A TACC3 PROGRAM Clinical Progress in Womens Cancers.
About A2A
Recent Funding lists A2A under Health and bio. It went through IndieBio (IndieBio SF 04). It was founded by Edward Painter.
Funding rounds
- Website created
- IndieBio SF 04
IIndieBio · batchSource: indiebio.co
Founders and team
- EPEdward Painter Chairman & CIO, Foundersource: a2apharma.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
A2A: questions and answers
- Who invested in A2A?
- Investors on record for A2A: IndieBio.
- Who founded A2A?
- A2A was founded by Edward Painter (Chairman & CIO, Founder).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/a2a (get a free API key).